Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
P. aeruginosa, a type of bacteria, is increasingly drug-resistant, and there's no vaccine against it. But it has a recently discovered Achilles heel.
Understanding the roles of various microbes in the human microbiome is challenging, but statistics can help, Stanford researcher Susan Holmes explains.
Scientists have created an algorithm that works to generate and refine DNA sequences that are likely to code for antimicrobial proteins.
By learning more about the flows generated by a biofilm, researchers may discover new ways to cut off its supply of nutrients.
New research examines how Zika viruses enter cells and shows that their behavior is different than that of some related viruses.
Changes in gut bacteria composition are correlated with the transition from hunting and gathering to farming, a new Stanford study shows.
Your trillions-strong ecosystem of gut microbes, in addition to its many other responsibilities, operates as a homespun pharmaceutical factory.
A profile by The Scientist of Lucy Shapiro, PhD, highlights her career and the passions that guided her groundbreaking scientific research.
Stanford scientists have discovered the signaling pathway responsible for making sure all DNA is replicated before cell division can occur.
Your cells can die in several ways, and that's not necessarily a bad thing. This piece explains four types of cell death.
Propionate molecules made by intestinal bacteria inhibits growth of Salmonella and may be a promising new treatment for gut infections.
What if you could stitch together single cells any way you wanted to? Potential medical and even industrial applications abound.
Found in about half of all bacterial species, the cell membrane that surrounds the cell wall may be more critical for survival than previously thought.
Today, diagnosing rare genetic diseases requires slow, educated guesswork, but a team of Stanford experts is automating the process.
In an interview, Stanford bioengineer Michael Fischbach discussed the growing knowledge of the bacteria in our bodies and what that means for the future of medicine.
